Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 μ g day−1) versus HFA-fluticasone propionate (1000 μ g day−1) in patients with asthma

This publication has 17 references indexed in Scilit:

• Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
  Journal of Allergy and Clinical Immunology, 1999
• Differences in lung bioavailability between different propellants for fluticasone propionate
  The Lancet, 1999
• A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers
  International Journal of Pharmaceutics, 1999
• Systemic Adverse Effects of Inhaled Corticosteroid Therapy
  Archives of internal medicine (1960), 1999
• Fortnightly review: Modern drug treatment of chronic asthma
  BMJ, 1999
• Hydrofluoroalkane-134a Beclomethasone Dipropionate, 400 μg, Is as Effective as Chlorofluorocarbon Beclomethasone Dipropionate, 800 μg, for the Treatment of Moderate Asthma
  Chest, 1999
• The relationship of serum-eosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma
  Pediatric Allergy and Immunology, 1998
• Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma
  Clinical and Experimental Allergy, 1998
• A comparison of the efficacy and safety of inhaled corticosteroids in asthma
  Allergy, 1997
• A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma
  Chest, 1993